GL1X · GenesisL1 explorer

Research workbench

HIV-1 integrase catalytic core domain A128T mutant complexed with allosteric inhibitor

Analyse HIV-1 integrase catalytic core domain A128T mutant complexed with allosteric… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4GVM
Type
protein
Length
148 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Gag-pol polyprotein
EC
3.4.23.16, 2.7.7.49, 2.7.7.7, 3.1.26.13, 3.1.13.2
UniProt
P12497
Ligands
LF2, ARS

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGag-pol polyprotein (EC 3.4.23.16, 2.7.7.49, 2.7.7.7, 3.1.26.13, 3.1.13.2)protein14846% helix, 22% strandP12497

Ligands and binding sites

  • LF2 · (2S)-[6-bromo-4-(4-chlorophenyl)-2-methylquinolin-3-yl](tert-butoxy)ethanoic acid · ligand · chains A
  • ARS · Arsenic · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 4GVM · HIV-1 Integrase Catalytic Core Domain A128T Mutant Complexed with Allosteric Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.